CN110121329A - Local skin blast additive and composition with amino acid and PPAR activation fatty acid - Google Patents
Local skin blast additive and composition with amino acid and PPAR activation fatty acid Download PDFInfo
- Publication number
- CN110121329A CN110121329A CN201780079471.8A CN201780079471A CN110121329A CN 110121329 A CN110121329 A CN 110121329A CN 201780079471 A CN201780079471 A CN 201780079471A CN 110121329 A CN110121329 A CN 110121329A
- Authority
- CN
- China
- Prior art keywords
- acid
- composition
- skin
- composition according
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Abstract
Skin lightening additive and personal care composition containing amino acid and PPAR activation fatty acid cpds.The composition can be used for obtaining even skin tone and reduce pigmentation, senile plaque and discoloration.
Description
Technical field
Topical composition the present invention relates to skin lightening additive and comprising the additive.
Background technique
Many consumers are concerned about their skin characteristic.For example, consumer is concerned about the pigmentation level of their skins, sparrow
Spot and/or senile plaque.Other consumers wish to reduce dimmed by being exposed to sun-induced skin.In order to meet the need of consumer
It asks, many trials has been carried out to develop the product for improving skin characteristic.However, the product developed so far often tends to have
There are low effect, undesirable side effect or both to have both at the same time.The more and more interesting exploitation of people adds comprising new skin lightening
Add the cosmetic composition of agent.
The tripeptides that glutathione (GSH) is made of glutamate, cysteine and glycine.It is present in all lactations
In animal tissue.It is the primary anti-oxidant in living body: it protects cells from oxidation by quenching activity oxygen species.Carefully
The damage of born of the same parents' content increased GSH protection cells from oxidative, toxic chemical and radiation (Meister, J.Biol.Chem.263:
205—217,1988;Meister,Science 200:471—477,1985).Although all areas of body be all as
This, but this is especially important in skin, and skin is greatly exposed to the destructiveness of radiation, particularly UV radiation and environmental contaminants
Effect.The reduction of the intracellular concentration of skin GSH-PX activity and cellular damage, inflammation, skin are dimmed, change colour, by being exposed to purple
The correlations such as spot caused by external radiation or freckle, physiological aging.
A kind of realization skin lightening and/or confrontation skin is dimmed, discoloration or pigmented logical method seem
It is that the GSH of exogenous source (such as by intake or local delivery) is provided to cell.In fact, GSH has been used as skin sometimes
The sale of skin blast ingredient.Unfortunately, GSH is not bioavailable in exogenous application, i.e., in extracellular positioning,
GSH is broken down into it and forms amino acid (glutamate, cysteine and glycine), cellular uptake and conjunction for GSH tripeptides
At.Therefore, GSH is not directly transferred into cell, therefore itself not will lead to the intracellular of GSH and increased or associated appoint
What benefit.Cysteine is one of GSH amino acid, can increase the cell content of GSH, but the sulfydryl of cysteine exposure makes
Its is unstable and has reactivity, and also causes strong undesirable smell.Different from cysteine, cystine can pacify
Full application;Cystine is transported in cell and is converted into cysteine in the cell, and then cysteine can be used for into the cell
The generation of GSH.
The topical composition containing various amino acid and other skin care active objects has been described, see, for example,
The US7300649 of Tanojo, Laboratoire Filorga product, Schlachter WO 00/03689, Ermolin etc.
US 8,361,446, the Hermann's of US4,707,354, Muller of US2011183040, Garlen etc. etc. etc.
US8241681.The composition for enhancing glutathion inside cell generation has been described.See, for example, the U.S. of Chiba etc.
Patent 7,740,831, Crum etc. (USRE37934, USRE42645, WO2016/033183 and US20050271726);
The United States Patent (USP) 6,149,925 of Mammone and the US 20060063718 of Perricone.
Cystine is typically derived from diet.It is challenging however, delivering cystine from topical composition, because
Its solubility in neutral pH range in biologically acceptable carrier is extremely low, and the pH range is needed for part applies
PH range.The solubility of cystine in water is 0.112mg/ml at 25 DEG C;Cystine is more soluble in pH and is higher than less than 2 or pH
In 8 aqueous solution.
The present invention is based partially on it has surprisingly been found that i.e. comprising the modified of cystine, glutamate and glycine
What the combination of GSH module (block) ispol and PPAR activation fatty acid realized skin lightening cooperates with increase, therefore
The shortcomings that counteracting the low solubility of cystine.
Summary of the invention
In one embodiment, personal care composition according to the present invention includes:
In one embodiment, topical cosmetic dermal compositions are leave-on compositions, and especially leave is non-solid
Body composition.
In one embodiment, the present invention provides the method for improving skin appearance comprising applies the office to skin
Portion's cosmetic skin composition.
In one embodiment, the present invention provides the method for improving skin appearance comprising applies personal shield to skin
Manage composition.
In one embodiment, the present invention provides obtain even skin tone and reduce pigmentation, senile plaque and discoloration
Method comprising apply the composition to skin.
Composition of the invention is by even skin tone, skin lightening, counteracting by being exposed to UV light/daylight or environmental contaminants
Caused by discoloration, pigmentation, senile plaque and skin it is dimmed, improve the skin due to caused by aging at any time or light aging
Appearance.The preferred method for obtaining the benefit of composition is applied by regular/long-term part of composition, to prevent even day
It often is exposed to the development for the skin injury that UV light may cause.
The detailed description of invention
In entire disclosure and claims, unless the context clearly determines otherwise, otherwise following term uses this
Civilized really relevant meaning.
It phrase " in one embodiment " as used herein and is not necessarily meant to refer to " in some embodiments " identical
Embodiment, although it can refer to identical embodiment.In addition, phrase " in another embodiment " as used herein
" in some of the other embodiments " is not necessarily meant to refer to different embodiments, although it can refer to different embodiments.
Therefore, as described below, without departing from the scope or spirit of the invention, various realities of the invention can easily be combined
Apply scheme.In addition, with regard to each embodiment that various embodiments of the present invention provide be intended to be illustrative and not restrictive.
In addition in embodiment or it is otherwise explicitly indicated in the case where other than, the amount or anti-of material is indicated in this specification
All numbers of condition, the physical property of material and/or purposes are answered to should be understood as being modified by word " about ".Unless otherwise saying
Bright, otherwise all amounts are with the poidometer of final composition.The disclosure found herein should be considered covering
All embodiments found in mutual claim are subordinated to multiple, without considering in no multiple subordinate or redundancy
In the case where it may be found that claim the fact.It is any specific more highly concentrated in any range of prescribed concentration or amount
Degree can be associated with any specific low concentration or amount.
" comprising " is intended to mean "comprising", but be not necessarily " by ... form " or " by ... constitute ".In other words, institute
The step of column or option need not be exhaustive.
" skin " is intended to include on face, neck, chest, back, arm (including oxter), hand, leg, buttocks and scalp
Skin.
" leave-on composition " refers to following composition, is applied to skin, with after application immediately or a few minutes just wash
The skin cleaning going or wash off washes off type or rinse-off compositions are compared, and whithin a period of time, does not beat in a few houres especially
Calculation is washed away or is washed off.
It is " non-solid " for the composition mean the composition have 1Pas to 500Pas, preferably 2Pas extremely
Within the scope of 100Pas, more preferable 3Pas to 50Pas measurable viscosity (such as can with Brookfield viscometer DV-I+ (20RPM, RV6,
30 seconds, 20 DEG C) measurement).
" personal care composition " refers to application as human body for improving appearance, sun-proof, cleaning, smell control, moisturizing
Or general beautiful any product.The non-limiting example of personal care composition include skin care milk, creme (cream), gel,
Emulsion (lotion), facial mask, stylus, shampoo, conditioner, bath gels, toilet bars, antiperspirant, deodorant, shaving cream,
Depilatory agent, lipstick, foundation cream, mascara, Sunless tanning agent and sunscreen.
" skin cosmetic composition ", which refers to, is applied to human body for improving appearance, sun-proof, reduction wrinkled appearance or other
Light aging sign, smell control, skin lightening, even skin tone or general aesthetics any product.Topical cosmetic skin group
The non-limiting example for closing object includes skin care milk, creme, facial mask, gel, stylus, antiperspirant, deodorant, lipstick, foundation cream, eyelashes
Cream, liquid or gel shower cream, soap bar, Sunless tanning agent and sunscreen.
The non-solid skin cosmetic composition of the preferred leave of the personal care composition of this technology, because due to cystine
Solubility is low and most challenging in terms of mixing cystine.
Modified glutathione (" GSH ") amino acid
GSH ispol according to the present invention includes amino acid (glutamate, cystine and glycine).
Comprising amino acid in the compositions of the present invention with the presence of L stereoisomer, because this is to find in nature
Most abundant and natural isomeric form.Due to the structure of the naturally occurring protein found in application on human skin, hair and nail
Modeling block is the amino acid with L isomeric form, it is therefore expected that L stereoisomer contained in personal care product of the invention
Amino acid can have the bigger interaction with these protein, in itself inherently compared with D stereoisomeric forms in any ratio
More bio-compatible.In addition, the commodity production and supply of L stereo isomer amino acids are significant compared with D stereoisomer form
It is higher.Finally, compared with D stereo isomer amino acids, the production of L stereo isomer amino acids get up it is also more cost effective, more
It is sustainable, more ecological close friend, and can be obtained with lower cost.
Comprising any amino acid in the present invention can in the form of salt, ester or its salt, and in this specification it is used
Term " cystine ", " glutamic acid Yanyuan " and " glycine " also cover the salt of salt, ester and such ester.Salt, ester and such ester
Salt is not particularly limited, as long as it is acceptable part application.For example, can be mentioned that and inorganic acid or organic acid or yin
The salt of ionic surfactant.As inorganic acid, can be mentioned that such as hydrochloric acid, hydrobromic acid, nitric acid, sulfuric acid, phosphoric acid, as straight
Chain, branch or ring-type, saturation or unsaturation, it is unsubstituted or through hetero atom replace C1-C18 organic acid, can be mentioned that such as formic acid,
Acetic acid, trifluoroacetic acid, propionic acid, lactic acid, tartaric acid, oxalic acid, fumaric acid, succinic acid, maleic acid, citric acid, malonic acid, methylsulphur
Acid, stearic acid, oleic acid, 12- hydroxy stearic acid, ricinoleic acid etc..
As the salt with alkali, can be mentioned that such as alkali metal salt as sodium salt, sylvite, alkali salt such as calcium salt, magnesium salts etc.
Deng.
The ester of amino acid is usually C1-C8Ester or its salt, or be selectively C1-C5Ester, or be selectively C1-C3Ester.
Such ester can be linear chain or branched chain or cricoid.The ester of especially cystine is beneficial, because compared with cystine, they
Solubility increase.The methyl esters and ethyl ester or its salt of cystine are most preferred, because they have the production for promoting glutathione
The effect of raw and offer antioxidant activity.When using the salt of ester, identical salt listed above is suitable.
Presence-glutamine, glutamic acid and/or burnt paddy ammonia can be used in the form of its functional equivalent in glutamic acid Yanyuan
Acid and/or their ester or salt.It is preferred that pyroglutamic acid (and/or its salt), because it is more more stable than glutamine or glutamic acid.?
In one embodiment, skin lightening additive includes cystine and pyroglutamic acid and glycine (and/or its salt).
PPAR activates fatty acid
The fatty acid for being suitable as skin lightening additive of the invention includes but is not limited to: 12- hydroxy stearic acid, conjugation
Linoleic acid, ricinoleic acid, petroselic acid, cis- -9- anti-form-1 1- conjugated linoleic acid, cis- -12 conjugated linoleic acid of anti-form-1 0-, 7-
Trans- octadecanoid acid, cis--parinaric acid, docosahexaenoic acid, two dodecahexaene of cis- -4,7,10,13,16,19-
Acid, ricinelaidic acid (ricinolaidic acid), parinaric acid (stearidonic acid), octatecatrienoic acid
(columbinic acid), anti-linolenic acid, vaccenic acid, eicosapentaenoic acid, Pinolenic acid (pinolenic acid) and it
Mixture.It has been found that skin lightening collaboration increases by means of including that amino acid as described herein and PPAR activate fatty acid
The shortcomings that adding, therefore overcoming cystine limited solubility.
In one embodiment, composition of the invention is the personal nursing that pH is 3.5 to 8.5, pH in particular 5 to 8
Topical creams, emulsion, gel, creme or toilet cream form leave inventive non-solid compositions, it includes cystines, glutamate
The skin lightening additive of (especially pyroglutamic acid or its salt, such as sodium pyroglutamate), glycine and 12- hydroxy stearic acid.
In one embodiment, composition of the invention is the personal nursing that pH is 3.5 to 8.5, pH in particular 5 to 8
Topical creams, emulsion, gel, creme or toilet cream form leave inventive non-solid compositions, it includes cystines, glutamate
The skin lightening additive of (especially pyroglutamic acid or its salt, such as sodium pyroglutamate), glycine and conjugated linoleic acid.
In one embodiment, composition of the invention is the personal nursing that pH is 3.5 to 8.5, pH in particular 5 to 8
Topical creams, emulsion, gel, creme or toilet cream form leave inventive non-solid compositions, it includes cystines, glutamate
The skin lightening additive of (especially pyroglutamic acid or its salt, such as sodium pyroglutamate), glycine and petroselic acid.
In one embodiment, composition of the invention is the personal nursing that pH is 3.5 to 8.5, pH in particular 5 to 8
Topical creams, emulsion, gel, creme or toilet cream form leave inventive non-solid compositions, it includes cystines, glutamate
The skin lightening additive of (especially pyroglutamic acid or its salt, such as sodium pyroglutamate), glycine and ricinoleic acid.
Amount
In one embodiment, cystine with 0.001% to 2% or selectively 0.005% to 1% or
0.008% to 0.5% or selectively 0.008% to 0.4% amount by comprising.In one embodiment, glutamic acid Yanyuan
(preferably pyroglutamic acid salt) is with 0.01% to 10% or selectively 0.01% to 5% or 0.05% to 1% or selectively
0.05% to 0.5% amount by comprising.In one embodiment, glycine source is with 0.01% to 10% or selectively
0.01% to 5% or 0.05% to 1% or selectively 0.05% to 0.5% amount by comprising.In one embodiment,
PPAR activates fatty acid with 0.01% to 5% or selectively 0.05% to 5% or 0.1% to 5% or selectively
0.1% to 3% amount by comprising.
In one embodiment, the total weight of amino acid is at least 10 times of the weight of PPAR activation fatty acid.One
In a embodiment, the weight ratio of total amino acid and PPAR activation fatty acid is in the range of 10:1 to 20:1.Selectively, always
The weight ratio of amino acid and resorcinol is in the range of 10:1 to 15:1.
Carrier
Composition of the invention also includes acceptable carrier on cosmetics.The amount of carrier can 1% to 99.9%, preferably
70% to 95%, best 80% to 90% range.Useful carrier have water, emollient, fatty acid, fatty alcohol, thickener and
Their combination.Carrier can be aqueous, anhydrous or lotion.Preferably, the composition is aqueous, especially oil packet
The water and fat liquor (water and oil emulsions) or W/O/W or Water-In-Oil packet oil of water or oil-in-water type become
The multiple emulsion of type.When it is present, the amount of water can 5 weight % to 95 weight %, preferably from about 20 weight % to about 70 weight %,
The range of best 35 weight % to 60 weight %.
Emollient materials can act on as carrier acceptable on cosmetics.These can in silicone oil, natural or synthetic ester,
The form of hydrocarbon, pure and mild fatty acid.The amount of emollient can be with the poidometer 0.1 to 95% of composition, preferably 1% to 50%
Arbitrary value in range.
Silicone oil can be divided into volatility and non-volatile type.Term " volatility " as used herein refers in environment temperature
Degree is lower to have those of measurable vapour pressure material.Volatile silicone oils are preferably selected from containing 3 to 9, preferably 5 to 6 silicon originals
The ring-type (Cyclomethicone) or linear polydimethyl siloxane of son.It includes poly- for can be used as the non-volatile silicone oil of emollient materials
Alkylsiloxane, Polyalkylaryl siloxane and polyether siloxane copolymer.It can be substantially non-volatile in this article
Polyalkylsiloxane includes having 5 × 10 for example at 25 DEG C-6To 0.1m2The dimethyl silicone polymer of the viscosity of/s.It can be used for
Preferred non-volatile emollients in this composition, which are included at 25 DEG C, has 1 × 10-5To about 4 × 10-4m2The viscosity of/s
Dimethyl silicone polymer.
Another kind of nonvolatile silicone is emulsification and non-emulsified silicone elastomer.The representative of the category is as Dow
Dimethicone/second that Corning 9040, General Electric SFE 839 and Shin-Etsu KSG-18 are obtained
Alkenyl dimethicone cross-linked polymer.Silicone wax also can be used, such as Silwax WS-L (the dimethicone copolyol moon
Cinnamic acid ester (Dimethicone Copolyol Laurate)).
In ester emollient, have:
A) Arrcostab of the saturated fatty acid with 10 to 24 carbon atoms.The example includes neopentanoic acid Shan Yu ester, different nonyl
The different nonyl ester of acid, isopropyl myristate and octyl stearate.
B) ether-ether, such as the aliphatic ester of ethoxylation saturated fatty alcohol.
C) polyol ester.Ethylene glycol fatty acid ester and di-fatty acid esters, diglycol monotertiary aliphatic ester and two are sweet
Alcohol di fatty acid ester, polyethylene glycol (200-6000) mono fatty acid ester and polyethylene glycol (200-6000) di fatty acid ester, the third two
Alcohol mono fatty acid ester and Propylene glycol di-fatty acid ester, 2000 monostearate of polypropylene glycol, ethoxylated propylene glycols monostearate
Ester, mono fatty acid glyceride and the poly- fatty ester of difatty acid glyceride, polyglycereol, ethoxylation glycerin monostearate, 1,3-
Butanediol monostearate, 1,3 butylene glycol distearate, polyoxyethylene polyol fatty acid esters, sorbitan fatty
Acid esters and polyoxyethylene sorbitan aliphatic ester are satisfactory polyol esters.Be especially useful that pentaerythrite,
Trimethylolpropane and C1-C30The neopentyl glycol ester of alcohol.
D) wax ester, such as beeswax, spermaceti and San Shan Yu essence wax (tribehenin wax).
E) sugar ester of fatty acid, such as the poly- behenic acid ester of sucrose and the poly- cottonseed acid esters of sucrose.
Natural ester emollients are based primarily upon monoglyceride, diglyceride and triglycerides.Representative glyceride include to
Day seed oil of sunflower, cottonseed oil, borage oil, Common Borage seed oil, evening primrose oil, castor oil and rilanit special, rice bran oil, soybean
Oil, olive oil, safflower oil, sher butter, jojoba oil and their combination.The emollient of animal origin is by lanolin oil and sheep
Hair rouge derivative represents.The amount of natural esters can be with the range of the poidometer 0.1% to 20% of the composition.
Hydrocarbon as acceptable carrier on suitable cosmetics includes vaseline, mineral oil, C11-C13Isoparaffin, poly- fourth
Alkene especially can be used as the isohexadecane that Permethyl 101A is commercially available from Presperse Inc..
Fatty acid with 10 to 30 carbon atoms can also be suitable as acceptable carrier on cosmetics.The reality of the category
Example is n-nonanoic acid, lauric acid, myristic acid, palmitinic acid, stearic acid, isostearic acid, oleic acid, linoleic acid, linolenic acid, hydroxy stearic acid
He behenic acid and their mixture.
Fatty alcohol with 10 to 30 carbon atoms is acceptable carrier on the cosmetics of another useful classification.The category
Example be stearyl alcohol, laruyl alcohol, myristyl alcohol, oleyl alcohol and cetanol and their mixture.
Thickener or rheology modifier can be used as one of acceptable carrier on the cosmetics of composition according to the present invention
Part.Typical thickener includes acrylate (such as the Carbopol of crosslinking), the acrylate (example of hydrophobically modified
Such as Carbopol), polyacrylamide (such as Sepigel), acryloyl methyl propane sulfonic acid/salt polymer and
Copolymer (such as AristoflexWith), cellulose derivative and natural gum.Spread out in useful cellulose
Biology, in have sodium carboxymethylcellulose, hydroxypropyl methyl cellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, ethyl cellulose
And hydroxymethyl cellulose.Suitable for natural gum of the invention include guar gum, xanthan gum, sclerotium, carrageenan, pectin and these
The combination of glue.Inorganic matter also be used as thickener, especially clay such as bentonite and hectorite, pyrolytic silicon dioxide, talcum,
Calcium carbonate and silicate such as aluminium-magnesium silicateThe amount of thickener can be 0.0001% to 10%, usual 0.001%
To 1% or 0.01% to 0.5% range.
Particularly with the product for being intended to be applied to face, the emollient for improving organoleptic properties may be preferably used for, and it is selected
From below group: -14 butyl ether of polypropylene glycol (also referred to as Tegosoft PBE) or PPG15 stearyl ether such as Tegosoft E, its
Its oil such as ester especially isopropyl myristate, isopropyl palmitate, other oil may include castor oil and its derivative.
The wetting agent of polyhydric alcohol-type can be used as acceptable carrier on cosmetics.Typical polyalcohol includes glycerol, gathers
Aklylene glycol and they pure and mild derivative of more preferable alkylene polyol, including it is propylene glycol, dipropyl glycol, polypropylene glycol, poly-
Ethylene glycol and its derivative, D-sorbite, hydroxypropyl sorbitol, hexylene glycol, 1,3 butylene glycol, isoprene, 1,2,6- oneself
Triol, ethoxylated glycerol, propoxylated glycerol and their mixture.The poidometer that the amount of wetting agent can be with composition
Arbitrary value in the range of 0.5% to 50% and preferably 1% to 15%.
It may include skin moisturizer, such as hyaluronic acid and/or its precursor N-acetyl-glucosamine.N-acetyl-glucosamine can be
It finds, and can be commercially available from Maypro Industries, Inc (New York) in Shark cartilage or mushroom.Other preferred guarantors
Humectant includes three (C of hydroxypropyl1-C3Alkyl) ammonium salt.These salt can be obtained with various synthesis technologies, most particularly by hydrolysis chlorine
Three (C of hydroxypropyl1-C3Alkyl) ammonium salt acquisition.Most preferred substance is 1,2- dihydroxypropyl trimethyl ammonium chloride, wherein C1-C3Alkane
Base is methyl.The amount of the salt can with the poidometer 0.2% to 30% of topical composition and preferably 0.5% to 20%, it is best
1% to 12% range, including all ranges included in it.
C on usual quaternized ammonium1-C3Alkyl component can be methyl, ethyl, n-propyl, isopropyl or ethoxy and
Their mixture.Particularly preferably it is known as the trimethyl ammonium group of " trimethylammonium (trimonium) " group by INCI nomenclature.
Any anion is used equally in the quaternary ammonium salt.Anion can be organic or inorganic, and condition is that the material is makeup
It is acceptable on product.Typical inorganic anion is halogen ion, sulfate radical, phosphate radical, nitrate anion and borate.Most preferably halogen from
Son, especially chloride ion.Organic anionic counter ions include methyl-sulfuric acid root, toluoyl sulfate, acetate, citrate,
Tartrate anion, lactate, glucose acid group and benzene sulfonic acid root.
It include the urea replaced especially in combination with other still preferred moisturizer workable for above-mentioned ammonium salt, such as methylolurea, hydroxyl
Ethyl carbamide, hydroxypropyl urea;Bis- (methylol) ureas;Bis- (ethoxy) ureas;Bis- (hydroxypropyl) ureas;N, N '-dimethylol urea;N,N'-
Dihydroxy ethyl urea;N, N '-dihydroxypropyl urea;N, N, N '-trihydroxyethyl urea;Four (methylol) ureas;Four (ethoxy) ureas;Four (hydroxyls
Propyl) urea;N- methyl, N '-ethoxy urea;N- ethyl-N '-ethoxy urea;N- hydroxypropyl-N '-ethoxy urea and N, N ' diformazan
Base-N- ethoxy urea.When term hydroxypropyl occurs, the meaning is to 3- hydroxy-n-propyl, 2- hydroxy-n-propyl, 3- hydroxyl isopropyl
Base or 2- hydroxyisopropyl are general.Most preferably ethoxy urea.The latter can be using trade mark Hydrovance as 50% water
Property liquid is obtained from the National Starch&Chemical Division of ICI.In topical composition for use in the present invention
Substituted urea range of the amount 0.01% to 20% or 0.5% to 15% or 2% to 10%.When use ammonium salt and/or substitution
Urea when, in embodiment most particularly preferably, use at least 0.01% to 25% or 0.2% to 20% or 1% to 15%
Wetting agent, such as glycerol.It include vaseline and/or various aquaporins operation active matter with other moisturizer in this article
And/or oat kernel powder.
The pH of composition
In one embodiment, the pH of personal care composition is 3.5 to 8.5.In some embodiments, personal shield
The pH for managing composition is pH 3.5 to pH 8.In some embodiments, the pH of personal care composition is pH 5 to pH 7.8.
In some embodiments, the pH of personal care composition is 5 to 7.5.
Preferred optional member
In some embodiments, personal care composition of the invention and especially leave skin cosmetic composition
Contain sun-screening agent.These are usually the combination of Orangic sunscreen and inorganic sunscreen.It is especially important that UV-A and UV-B to be included
Radiate sun-screening agent.
UV-B sunblock lotion can be selected from the classification of cinnamic acid, salicylic acid, diphenylacrylate or derivatives thereof.UV-B sunblock lotion
It may include one of following or a variety of: octyl salicylate, 2 hydroxybenzoic acid 3,3,5- 3-methyl cyclohexanol ester, salicylic acid ethyl
Own ester, 2- cyano -3,3- diphenyl -2- 2-EHA or Ethylhexyl Methoxycinnamate (also referred to as first
Oxygroup cinnamic acid monooctyl ester or " OMC ").Such UV-B sunblock lotion is usually available commercially, such as OctisalateTM(bigcatkin willow is misery
Ester), HomosalateTM(2 hydroxybenzoic acid 3,3,5- 3-methyl cyclohexanol ester), NeoHeliopanTMA series of (organic UV mistakes
Filtering agent, including OMC (Neo Heliopan AVTM) and ethylhexyl salicylate (Neo Heliopan OSTM))、
OctocryleneTMWith Milestab 3039TM(2- cyano -3,3- diphenyl -2- 2-EHA) or Parsol
MCXTM(Ethylhexyl Methoxycinnamate).The amount of UV-B sunblock lotion can be 0.1 weight % in personal care composition
To 20 weight % or 0.2 weight % to 10 weight % or 0.5 weight % to 7 weight % or 2 weight % to 6 weight %.
Personal care composition can further include water-soluble UV-B sun-screening agent.Water-soluble UV-B sun-screening agent may also include benzene
Base benzimidazole sulfonic acid (also referred to as ensulizole (ensulizole)), 4-aminobenzoic acid (also referred to as p-aminobenzoic acid or
" PABA ") or both.
The personal care composition of any one the embodiment above can further include 0.1 weight % to 10 weight %'s
UV-A sunblock lotion.UV-A sunblock lotion may include below one or more: 4- tert-butyl -4'- methoxy dibenzoylmethane
(" Avobenzone "), 2- methyldiphenyl formyl methylmethane, 4- methyl-dibenzoyl base-ethane, 4- isopropyldibenzoylmethane-
Methane, 4- butyldibenzoylmethane, 2,4- dimethyldibenzoylmethane, 2,5- dimethyl dibenzoyl first
Alkane, 4,4'- diisopropyl dibenzoyl methane, 2- methyl -5- isopropyl -4'- methoxy-dibenzoylmethane, 2- first
Base -5- tert-butyl -4'- methoxy-dibenzoylmethane, 2,4- dimethyl -4'- methoxy dibenzoylmethane, 2,6-
Dimethyl -4- tert-butyl -4'- methoxy-dibenzoylmethane, diethylamino-hydroxybenzoyl-hexyl-benzoate, according to camphane
Relax (ecamsule) or methyl anthranilate.The amount of UV-A sunblock lotion can be 0.5 weight % in personal care composition
To 7 weight % or 1 weight % to 5 weight %.
It include commercially available from BASF Corporation suitable for the other suitable sunblock lotion personal care composition
Those of obtain: Uvinul T-150 (Uvinul T 150;UV-B sunblock lotion), Uvinul A Plus (lignocaine hydroxyl
Benzoyl hexyl-benzoate;UV-A sunblock lotion), Tinosorb S (bis-ethylhexyloxyphenol methoxyphenyl triazine;UV-A and
UV-B sunblock lotion), Tinosorb M (di-2-ethylhexylphosphine oxide benzotriazole base tetramethyl butyl phenol;UV-A and UV-B sunblock lotion).Phenyl
Bisbenzimidazole tetrasulfonic acid ester disodium (Bisdisulizone disodium) can also reside in personal care composition.
The particularly preferred combination of UV-A sunblock lotion and UV-B sunblock lotion is Avobenzone and 4- methoxy cinnamic acid 2- second
The own ester of base.
In some embodiments, sun-screening agent is inorganic sunscreen.Nothing suitable for skin care compositions and methods of the present invention
The example of machine sun-screening agent includes but is not limited to microfine titanium dioxide, zinc oxide, polyethylene and various other polymer.Term is " micro-
Carefully " mean particle of the average-size in 10-200 nanometers or 20-100 nanometer range.When being present according to the present invention one
When in the skin nursing formulation of a little embodiments, the amount of sun-screening agent can 0.1% to 30% or 2% to 20% or
4% to 10% range.
Although may include selenium source, selenium source is preferably avoided in Topical skin care composition of the invention, because at certain
It is considered as skin sensitization agent under a little supervision governments form.Therefore, the amount of selenium is 0 to maximum 0.1% in this composition, or at most
0.05%, most preferably it is no more than 0.01%.
Other than the skin lightening additive being contained herein, composition of the invention preferably also includes skin lightening
Object is closed, to obtain optimal skin lightening performance with optimum cost.Illustrative substance is intacellin, lactic acid, isophthalic
Diphenol (resorcinol that 4- replaces, the disubstituted resorcinol of 2,5-, the disubstituted resorcinol of 4,5- and 4,6 disubstituted
Resorcinol, especially 4- hexyl resorcin, cresorcinol, 4- butyl resorcinol, 4- isopropyl meta-dihydroxybenzene,
Symwhite-337), niacinamide and derivative, arbutin, kojic acid, ferulic acid, quinhydrones, resorcinol derivatives (including two
Substituted resorcinol) and their combination.In one embodiment, such Skin lightening compounds are that tyrosinase inhibits
Agent is most preferably selected from by the compound of kojic acid, quinhydrones and other (non-4 resorcinols replaced).There are also by formula HOOC-
(CxHy) dicarboxylic acids that-COOH (wherein x=4 to 20 and y=6 to 40) is indicated, such as azelaic acid, decanedioic acid, oxalic acid, amber
Acid, fumaric acid, octadecene diacid (such as Arlatone DC) or their salt or their mixture, most preferably fumaric acid or
Its salt, especially disodium salt.It has been found that especially for skin lightening formulation, particularly preferred 12HSA and fumaric acid or its salt
Combination.The amount of these reagents can be with the poidometer of the composition about 0.1% to about 10%, preferably from about 0.5% to about 2%
Range.It is preferred that it is niacinamide or resorcinol, especially 4- that skin lightening according to the present invention, which is total to activating agent (coactive),
Alkyl-resorcin.
Another preferred component of the present composition is retinoids (retinoid).As used herein, " retinoids "
All natural and/or synthesis of the bioactivity with vitamin A in skin including vitamin A or retinol-like compounds
The geometric isomer and stereoisomer of analog and these compounds.The preferred retinol of retinoids, retinol ester (example
Such as, the C of retinol2-C22Arrcostab, including retinyl palmitate, retinoic acid ester, Vitamin A propionate), retinene and/or view
Yellow acid (including all-trans retinoic acid and/or 13CRA), the retinoids more preferably in addition to retinoic acid.These are changed
It is well-known in the art for closing object, and can be commercially available from many sources, such as Sigma Chemical Company
(St.Louis, Mo.) and Boerhinger Mannheim (Indianapolis, Ind.).It can be regarded with other classes in this article
Flavol is described in U.S. Patent No. 4,677,120 for giving Parish etc. on June 30th, 1987;On December 5th, 1989 is given
The U.S. Patent No. of Parish etc. 4,885,311;September in 1991 gives the U.S. Patent No. 5,049 of Purcell etc. on the 17th,
No. 584;On June 23rd, 1992 gives U.S. Patent No. 5,124,356 of Purcell etc.;It was given on September 22nd, 1992
The United States Patent (USP) of Purcell etc. is issued again in No. 34,075.Other suitable retinoids are retinoic acid Renascins (depending on Huang
The Renascin of sour (trans- or cis-)), Adapalene (adapalene) { 6- [3- (1- adamantyl) -4- methoxybenzene
Base] -2- naphthoic acid }) and tazarotene (tazarotene) (6- [2- (4,4- dimethylthiochroman -6- base)-acetylene
Base] ethyl nicotinate).Preferred retinoids are retinol, retinyl palmitate, retinoic acid ester, Vitamin A propionate, retinene
And their combination.Retinoids be preferably generally it is pure, it is more preferably substantially pure.Composition of the invention can contain
The retinoids safely and effectively measured so that resulting composition for adjust collenchyme illness, preferably for adjust skin in
The visible and/or discontinuity that can touch, more preferably for adjusting signs of skin aging, even more preferably for adjusting and skin
Discontinuity that is visible and/or can touching in the relevant skin texture of aging is safely and effectively.The composition preferably comprises
0.005% to 2% or 0.01% to 2% retinoids.Retinol preferably with or 0.01% to 0.15% amount use;Depending on Huang
Alcohol ester is preferably used with the amount of 0.01% to 2% (such as 1%);Retinoic acid is preferably used with 0.01% to 0.25% amount;And
And retinoic acid Renascin, Adapalene and tazarotene are preferably used with 0.01% to 2% amount.
Various herb extracts may be optionally contained in composition of the invention.Example is pomegranate, white birch (Betula
Alba), green tea, camomile, Radix Glycyrrhizae and its extract combination.The extract can be carried in solvent be respectively hydrophily or
Hydrophobic water-soluble or water-insoluble substance.Water and ethyl alcohol are preferred Extraction solvents.
Also may include material such as below: resveratrol, ellagic acid, kinetin, regards yellow oxygroup trimethyl at alpha-lipoic acid
Silane (can be obtained with Silcare 1M-75 trade mark from Clariant Corp.), dehydrobenzene (DHEA) and their combination.
Ceramide (including Cer EOS, Cer NP, Cer NP B, Cer AP and ceramide 7) and false manifestation of vitality are through acyl
Amine can also be used for many compositions of the invention, but can also be excluded.The amount of these materials can 0.000001% to 10%,
It is preferred that 0.0001% to 1% range.
Personal care composition can further include the film forming polymer of about 0.1 weight % to about 8 weight %.Such film forming
Polymer include but is not limited to polyalkylene oxygroup sealing end polyamide (for example, INCI title: Polyamide-3, polyamide -4),
Polyether-polyamide (for example, INCI title: polyamide -6), the polyamide for mixing acid blocked (for example, INCI title: polyamide -7)
With poly- (ester-acid amide) (for example, the INCI title: polyamide -8) of ester sealing end.Such film forming polymer can synthesize or commercially available
It arrives, such as with SylvaclearTMProduct line is purchased from Arizona Chemical Company, LLC and with OleoCraftTMIt produces
Strain column are purchased from Croda International PLC.Film forming polymer further includes but is not limited to the (example of polyester -5 of INCI name
Such as, Eastman AQTM38S polymer), PPG-17/IPDI/DMPA copolymer is (for example, AvalureTMUR 450 polymerize
Object), acrylate copolymer is (for example, AvalureTM120 polymer of AC) and polysaccharide such as Xilogel (tamarind gum
(tamarin gum))), lotus flower bean gum, tara gum, beta glucan, short mould polysaccharide, carboxymethyl cellulose, the hydroxy propyl cellulose of waking up
Element, mosanom, potato starch, carrageenan.Film forming polymer may include it is above-mentioned any two or more polymer combination.
The amount of film forming polymer can be 0.1 weight % to 8 weight % in personal care composition.
Preservative can desirably prevent the growth of potentially harmful microorganism in composition incorporated herein.For this
The suitable traditional preservatives of inventive composition are the Arrcostabs of P-hydroxybenzoic acid.The other preservative packets begun to use recently
Include hydantoin derivatives, propionate and various quaternary ammonium compounds.Cosmetic chemistry man is familiar with preservative appropriate, and conventional
Ground selects them to meet preservation challenge and test and provide product stability.Particularly preferred preservative is butylamino formic acid iodine
For propine base ester, Phenoxyethanol, pungent glycol (caprylyl glycol), C1-6P-hydroxybenzoate (especially para hydroxybenzene
Methyl formate and/or propylparaben), imidazolidinyl urea, dehydroactic acid sodium and benzylalcohol.Preservative should be according to composition
Purposes and preservative and lotion between other ingredients possible incompatibility select.Preservative preferably with 0.01% to
2% amount uses.Especially preferred combination is Octocrilene (octocrylene) and pungent glycol, because Xin Gan has been disclosed
Alcohol enhances UVA and UVB protection.
The antifungal agent being suitably included in personal care composition is well-known to those skilled in the art.Example includes
But be not limited to Climbazole, ketoconazole, Fluconazole, clotrimazole, Miconazole, econazole, etaconazole, Terbinafine, in these
Any one or more salt (such as hydrochloride), zinc pyrithione, selenium disulfide and its two or more combination.
In some embodiments, personal care composition of the invention includes vitamin.Illustrative vitamin is dimension
Raw element A (retinol), vitamin B2, vitamin B3 (niacin), vitamin B6, vitamin B12, vitamin C, vitamin D, dimension
Raw element E, vitamin K and biotin.The derivative of vitamin also can be used.For example, vitamin C derivatives include four different palmitinic acids
Acid ascorbyl ester, Ascorbic acid 2-phosphate magnesium and ascorbic acid glucoside.The derivative of vitamin E includes Tocopherol acetate ester, palm fibre
Palmitic acid acid Renascin and tocopheryl linoleate.DL-panthenol and derivative also can be used.In some embodiments, vitamin
B6 derivative is pyridoxine palmitate.Flavonoids, especially glucityl aurantiamarin, rutin sophorin and isoflavones also can be used
(including genistein, Daidzein, equol and their glycosyl derivative) and their mixture.When it is present,
The total amount of vitamin or flavonoids can 0.0001% to 10% or 0.001% to 10% or 0.01% to 10% or
The range of person 0.1% to 10% or 1% to 10% or 0.01% to 1% or 0.1% to 0.5%.
In some embodiments, personal care composition of the invention includes enzyme, such as such as oxidizing ferment, protease, rouge
Fat enzyme and their combination.In some embodiments, personal care composition of the invention include with Biocell SOD from
The superoxide dismutase that Brooks Company (U.S.) is commercially available.
In some embodiments, personal care composition of the invention includes Desquamation promoters.In some embodiments
In, personal care composition of the invention include 0.01% to 15% or 0.05% to 15% or 0.1% to 15% or
The Desquamation promoters of 0.5% to 15% concentration of person.
Illustrative Desquamation promoters include monocarboxylic acid.Monocarboxylic acid can be carbon chain lengths be at most 16 substitution or do not take
Generation.In some embodiments, carboxylic acid is alpha-hydroxy carboxylic acid compounds, beta-hydroxycarboxylic acids or polyhydroxycarboxyliacid acid.Term " acid " means not
It only include free acid, but also including its salt and its C1-C30Arrcostab or aryl ester, and by going water removal with formed it is cyclic annular or
Linear lactone structures and the lactone generated.Representative acid includes glycolic, lactic acid, malic acid and tartaric acid.In some implementations
In scheme, salt is ammonium lactate.In some embodiments, beta-hydroxycarboxylic acids are salicylic acids.In some embodiments, phenolic acid packet
Include ferulic acid, salicylic acid, kojic acid and their salt.
In some embodiments, at least one other component can based on the weight of composition 0.000001% to
10% or 0.00001% to 10% or 0.0001% to 10% or 0.001% to 10% or 0.01% to
10% or 0.1% to 10% or 0.0001% to 1% exists.Colorant, opacifier or grinding agent can also reside in this
In the composition of invention.Colorant, opacifier or grinding agent can based on the weight of composition 0.05% to 5% or 0.1%
To 3% concentration by comprising.
In some embodiments, personal care product of the invention also may include peptide, the pentapeptide being such as example commercially available
Derivative-MatrixylTM, can be commercially available from Sederma, France.In another example, in some embodiments,
Personal care product of the invention also may include carnosine.
Composition of the invention may include other optional components of wide scope.CTFA Cosmetic Ingredient
Handbook (second edition, 1992) (entire contents are herein incorporated by reference) is described suitable for the present composition
Commonly used in the various unrestricted cosmetics and drug ingedient in topical cosmetic skin care industry.Example includes:
Antioxidant, binder, bio-additive, buffer, colorant, thickener, polymer, astringent, aromatic, wetting agent,
Opacifier, conditioner, exfoliant, pH adjusting agent, preservative, natural extract, essential oil, skin sensing object (skin
Sensate), Skin Soothing Agent and skin healing agent.
The form of composition
Composition of the invention is preferably non-solid.The preferred leave-on composition of composition of the invention.Combination of the invention
Object preferably applies to stop leave-on composition on the skin.These leave-on compositions should be applied to skin and then exist
It is distinguished after product application or by the composition that washing, flushing, wiping etc. are removed during application.Commonly used in washing away
The surfactant of type (rinse-off) composition has the foam/fertilizer for allowing them to generate when in use and being easy to rinse
The physicochemical properties of soap bubble (lather);They can be made of anion, cation, both sexes and non-ionic mixture.
On the other hand, do not need that there is such property for the surfactant in leave-on composition.More precisely, due to leave
Composition is not intended to rinse out, they need to be nonirritating, it is therefore desirable to surfactant in leave-on composition
The total content of total content and anionic surfactant minimizes.The total content of surfactant is preferred in the present composition
1% to no more than 10%, more preferably less than 8%, most preferably up to 5%, most preferably at most 3%.
In some embodiments, anionic surfactant is present in leave skin care compositions and methods with following amount
In: with the poidometer 0.01% of composition to most 5%, perhaps with the poidometer 0.01% to 4% of composition or with combination
The poidometer 0.01% to 3% of object perhaps (is less than with the poidometer 0.01% to 2% of composition or be substantially absent
1%, or less than 0.1%, or less than 0.01%).In some embodiments, in skin care compositions and methods surfactant it is total
Content is no more than 10%, is perhaps lower than 8% or at most 5%.
In some embodiments, surfactant is selected from by anionic active object, non-ionic activity object, cation
Type active matter and amphiprotic activity object.
In some embodiments, nonionic surface active agent be have it is those of following: C10-C20Fatty alcohol is hydrophobic
Object or fatty acid hydrophobe are condensed with every mole of 2 to 100 mole ethylene oxide of hydrophobe or propylene oxide;With 2 to 20 moles
The C of alkylene oxide condensation2-C10Alkyl phenol;Ethylene glycol fatty acid ester and di-fatty acid esters;Fatty mono glyceride;It loses
Water D-sorbite list C8-C20Two C of fatty acid and anhydrosorbitol8-C20Fatty acid;With polyoxyethylene sorbitan and
A combination thereof.In some embodiments, nonionic surface active agent is in the following group: alkyl poly glucoside, sugared fatty acid amide
(such as methyl glucose amide) and trialkylamine oxides.
In the skin care compositions and methods of some embodiments according to the present invention, suitable amphoteric surfactant includes
Cocoamidopropyl, C12-C20The double both sexes base second of trialkyl betaines, Sodium Lauroamphoacetate and lauroyl
Sour sodium.
In the skin care compositions and methods of some embodiments according to the present invention, suitable anionic surfactant
Including soap, alkyl ether sulfate and alkylether sulfonate, alkyl sulfate and alkylsulfonate, alkylbenzene sulfonate, alkyl sulphur
Base succinate and dialkyl sulfosuccinates, C8-C20Acyl isethinate, C8-C20Alkyl ether phosphate, C8-C20Flesh
Propylhomoserin salt, C8-C20Acyl-lactate, sulfosalicylic acetate and their combination.
Composition of the invention is usually in the emulsion form that can be oil-in-water or Water-In-Oil.In some embodiments,
Personal care composition is toilet cream and creme or emulsion based on oil-in-water emulsion.Toilet cream matrix includes 5% to 40%
Fatty acid and 0.1% to 20% soap.In such creme, fatty acid is preferably essentially the mixing of stearic acid and palmitinic acid
Object, and the sylvite of the preferably described fatty acid mixt of soap, although the mixture of other counter ion counterionsl gegenions and they can be used.Snowflake
Fatty acid in cream base matter is commonly using the mixture that substantially (normally about 90% to 95%) is stearic acid and palmitinic acid
It is prepared by hystric acid.Typical hystric acid include the about 52-55% of total palmitinic acid-stearic acid mixture palmitinic acid and
45-48% stearic acid.Therefore, comprising hystric acid and its soap to prepare toilet cream matrix within the scope of the invention.It is especially excellent
Selecting the composition includes higher than 7%, preferably higher than 10%, more preferably higher than 12% fatty acid.Typical toilet cream matrix
By crystalline network structuring, and it is sensitive to the addition of various composition.
In one embodiment, personal care composition is formulated as with the cystine being substantially dissolved in water phase
Water-in-oil emulsion.In one embodiment, personal care composition is formulated as water in oil emulsion of the cystine in aqueous drop
Liquid, wherein at least 90% drop have 100 nanometers to 20 microns or selectively 200 nanometers to 20 microns or to 10 microns
Diameter in range.
In some embodiments, other than containing skin lightening additive, also personal care composition is formulated as
Facial mask.In some embodiments, other than containing skin lightening additive, also according in U.S. Patent No. 5139771
Personal care composition is formulated as facial mask by the formula.In some embodiments, in addition to containing skin lightening additive
Except, personal care composition is formulated as facial mask also according to formula described in U.S. Patent No. 4933177.In some realities
It applies in scheme, in addition to containing other than GSH precursor, also according to formula described in U.S. Patent No. 6001367 by personal nursing
Composition is formulated as facial mask.
In some embodiments, other than containing skin lightening additive, also personal care composition is formulated as
Shampoo.In some embodiments, personal care composition of the invention is formulated as deodorant.In some embodiments
In, other than containing skin lightening additive, individual is protected also according to formula described in U.S. Patent No. 7,282,471
Reason composition is formulated as deodorant.In some embodiments, personal care composition of the invention is formulated as antiperspirant.?
In some embodiments, other than containing skin lightening additive, described in U.S. Patent No. 7,282,471
Personal care composition is formulated as antiperspirant by formula.
In some embodiments, personal care composition of the invention is formulated as the personal nursing l Water Paper being intended for single use
Towel product.In some embodiments, other than containing skin lightening additive, also according to U.S. Patent No. 7,282,471
Personal care composition is formulated as the personal nursing hygenic towelette product being intended for single use by the formula described in number.
In some embodiments, personal care composition of the invention is formulated as soap bar.In some embodiments,
In addition to containing other than skin lightening additive, also according to formula described in U.S. Patent No. 7,282,471 by personal nursing
Composition is formulated as soap bar.
The method for preparing skin care compositions and methods
In some embodiments, skin care compositions and methods according to the present invention can be prepared in the following manner:
A. all water soluble ingredients (including preservative, thickening polymer, the glycerol being optionally present) and water are mixed;
B., the mixture is heated to 70-90 DEG C of temperature;
C. all oil-soluble ingredients and formula (1) compound are mixed to 70-90 DEG C of temperature;
D. mixed oil-soluble ingredients are added in the mixture of water soluble ingredient heating, and mixed by agitation
It closes, mixture is maintained to 70-90 DEG C of temperature;With
E. mixture is cooled to room temperature while mixing.
In some embodiments, personal care composition of the invention is prepared by the way that lotion is made.
A. by cystine it is expected that content is dissolved in high pH (9 to 14 or 9 to 12) aqueous solution,
B. the thick lotion in oil is prepared with the solution and emulsifier, then,
C. acidic aqueous solution is added under mixing, obtains lotion of the pH in the neutral range needed for topical composition, most
Afterwards,
D. so that the lotion is subjected to high shear or is homogenized or sound spectrum processing (sonolation) step, such as pass through homogeneous
Device, such as the Nano DeBee homogenizer of BEE International (Massachusetts, USA) or by Sonic
Sonolator (Sonolator) homogenizer of Corporation (Connecticut, USA) manufacture carries out, to generate neutrality
The uniform final lotion of pH range is more than the diameter of 90% drop in 100 nanometers to 20 microns of size range.
Use the method for skin care compositions and methods
In some embodiments, skin care compositions and methods are locally applied to application on human skin.In some embodiments, institute
State skin care compositions and methods provide it is at least one selected from the benefit in the following group: skin condition, skin are smooth, reduce corrugation or old
The skin of change reduces scytitis, reduces dry, reduction senile plaque, reduction sunburn and blast skin.
In some embodiments, by a small amount of skin care compositions and methods, such as 1 to 5ml, from suitable container or applicator
It is applied to the exposed region of skin, and if desired, is then spread in skin using hand or finger or suitable device
Above and/or wipe into skin.
Referring now to following embodiment, illustrated the present invention together with above description with non-limiting example some
Embodiment.
Specific embodiment
Embodiment
Experimental method
The powder of following amino acid (glutamine and glycine) is purchased from Sigma, and by rebuilding in water (pH 7)
The powder prepares the single mother liquor for carrying out every kind of amino acid.It is female that cystine (Sigma) is generated in 0.5M sodium hydroxide (pH 12)
Liquid, because cystine is insoluble in neutral solution.As cystine ester l-cysteine di tert butyl carbonate dihydrochloride (DTBC) and
L-cysteine diethylester dihydrochloride (DEC) is purchased from Bachem;L-cysteine dimethyl ester dihydrochloride (CDME) comes from Sigma.
In order to generate the described herein after mixture for GAP, by three kinds of amino acid (glutamine, cystine and glycine) of proper volume
Merge in Han Keshi balanced salt solution (Hank's Balanced Salt Solution) (Sigma), so that glutamine,
The weight ratio of cystine and glycine is 0.5:1:1.Specific concentration used in each measurement (assay) see below.
Other test agent: 12- hydroxy stearic acid (Biotor Industries Pvt Ltd) is usually dissolved in second
In alcohol or dimethyl sulfoxide.In following measurement, in appropriate circumstances, solvent is added in intermedium control sample, with
Potential solvent effect is normalized.
Melanin content measurement
Making one primary melanocyte, (Cascade Biologics is now having for ThermoFisher Scientific)
There is the melanin of human melanoma cell growth replenishers (two kinds of nutrient media components from ThermoFisher Scientific)
Growth in cell growth medium (MGM).By melanocyte with 5 × 104A cells/well is seeded in 24 orifice plates, and is being added
In 37 DEG C and 5%CO in wet incubate box2It is incubated under atmosphere.Incubate 24 hours after, with alone or in combination GAP amino acid or
12- hydroxy stearic acid handles cell culture.Intermedium control is by with medium GAP (0.002mMNaOH) and/or other survey
The cell composition of agent medium of having a try processing.After treatment, by cell again in humidification incubate box in 37 DEG C and 5%CO2Gas
It is incubated 72 hours under atmosphere.At the end of 72 hours incubations, with 120 μ L/ hole melanin contents measurement reagent (in 1M sodium hydroxide
Culture medium 10%DMSO) is replaced, and is incubated 1 hour at 60 DEG C in the incubate box of oscillation.Then supernatant is transferred to 384
Orifice plate.The absorbance of 405 nanometers is measured using microplate (GEnios Pro, Tecan) by spectrophotometric analysis.
Untreated cell (inactive) is considered as 100% melanin content in the spectrophotometric optical density of 405 nanometers.
Utilize the relative black cellulose content of the normalization calculation processing sample based on untreated (culture medium/medium) control.
Glutathione measurement
By Human keratinocytes (Promocell, Heidelberg, Germany) have contain 5%CO2Atmosphere
Humidification incubate box in be maintained at 37 DEG C containing 60 μM of calcium chloride and 1% Human keratinocytes growth replenishers (come from
Two kinds of nutrient media components of ThermoFisher Scientific)In culture medium.The culture of update in every 2-3 days
Base.Then, cell is paved with carry out trypsin digestion with 90%, and with every hole 1 × 104A density is seeded to white wall
In 96 orifice plates of clear bottom.One day or two days after inoculation, cell culture was replaced with Han Keshi balanced salt solution (HBSS)
Base, and with individually or combined with other above-mentioned test agent GAP (or 0.12-0.240mM sodium hydroxide intermedium control,
PH 7.5) or individually l-cysteine ester pre-processes keratinocyte 1-2 hours.It constitutes mixed for the GAP in the measurement
The concentration for closing all amino acid of object is specified in tables of data, and is fully described in following abbreviated list.
With GAP alone or in combination or after other test agent pre-processes one hour or two hours, then with 25 μM of first
A kind of naphthoquinones (Sigma-Aldrich) (known oxidative stress inducer) challenge keratinocyte.After 18-20 hours,
It harvests cell and analyzes total glutathione content, the reagent using commercial reagent box (GSH-GSSG GLo Assay, Promega)
Box is for detecting the fluorescence-based system with total glutathione in quantitative culture cell.In short, being gone after cell processing
It is replaced 5 minutes at 20-25 DEG C except culture medium and with cell cracking agent;Note that all remaining steps also at 20-25 DEG C into
Row.Next, luciferase generation reagent to be added in each hole and incubate 30 minutes.After this step, by fluorescein
Detection reagent is added in each hole and incubates plate 15 minutes.Finally, then in 3 plate reader of FlexStation
Shining for plate is read in (Molecular Devices).After standard curve interpolation glutathione concentrations, total gluathione is calculated
Peptide content.Experiment condition usually at least to repeat to determine progress three times.Use single factor test ANOVA computational statistics conspicuousness.It is logical
It crosses and calculates protection percentage in following equation using the glutathione content of the calculating from each experiment:
Active oxygen species (ROS) measurement
By Human keratinocytes (Promocell, Heidelberg, Germany) have contain 5%CO2Atmosphere
It is maintained at 37 DEG C in humidification incubate box and grows replenishers (HKGS) containing 60 μM of calcium chloride and 1% Human keratinocytesIn keratinocyte culture medium.Every other day update culture medium.Then, cell is paved with carry out pancreas with 90%
Protease digestion, and with every hole 1-2 × 104A density is seeded in 96 orifice plates with black wall and clear bottom.It is being inoculated with
Afterwards second day, with or without menadione (10-25 μM), GAP, GAP medium (0.2mM NaOH, pH 7.5), above-mentioned
The combination of other test agent or GAP with other test agent or the Han Keshi balance salt of individual l-cysteine ester are molten
Liquid (HBSS) replaces cell culture medium, and incubates again 18 hours.For ROS detect, by CellROX it is green (Life Tech,
Thermo Fisher Scientific, Rockford, USA) reagent is added to the ultimate density of each Kong Zhongzhi 15-25 μM,
And it is incubated again at 37 DEG C 2-4 hours in humidification incubate box.It uses Tecan microplate (excitation/emission=490/525)
Detect ROS fluorescence.Opposite ROS is calculated using the normalization handled based on the intermedium control for being set as 100% to generate.It is pointing out
In the case where, the Relative fluorescence units in following equation using measurement calculate protection percentage, individually locate as with menadione
The comparison of reason:
ROS content is evaluated together with cell viability, because if processing toxicity is so big, so that making in measurement
Cell death (and there is no any detectable ROS), then may obtain the false negative of ROS.If cell is still survived,
The reduction of ROS content is meaningful.
Cell viability measurement
Human keratinocytes (Promocell, Heidelberg, Germany) are maintained at containing 60 μM of calcium chloride and
1% Human keratinocytes grow replenishers (HKGS's)In keratinocyte culture medium.Every other day update
Culture medium.Then, cell is paved with carry out trypsin digestion with 90%, and with every hole 2 × 104A density is seeded to 96 holes
In hyaline tissue's culture plate.Second day after inoculation, cell culture was replaced with the processing as described in ROS above measurement part
Base.After 18 hours, by cell culture kit -8 (CCK-8) reagent (Dojindo, Kumamoto, Japan) in HBSS with
1:10 dilution, and incubated together with cell at 37 DEG C 4 hours in the incubate box of humidification.It is read using Tecan Safire2 plate
Number device measures the light absorption of 450 nanometers.It is calculated using the normalization compareed based on the carrier intermediate for being set as 100% opposite
Vigor.
In the case where pointing out, the relative absorbance units in following equation using measurement calculate protection percentage, make
For compared with menadione is individually handled:
Abbreviation in embodiment is as follows:
MM=mMs
μM=micromole
μ L=microlitre
GAP=glutamine (32 μM), cystine (40 μM), glycine (129 μM)
HR=4- hexyl resorcin
The sodium pyroglutamate of GAP 10=8 μM, 10 μM of cystine, 32 μM of glycine
The sodium pyroglutamate of GAP 20=16 μM, 20 μM of cystine, 64 μM of glycine
The sodium pyroglutamate of GAP 60=48 μM, 60 μM of cystine, 192 μM of glycine
DEC=L- cystamine diethyl phthalate dihydrochloride
CDME=L- cystine dimethyl dihydrochloride
DTBC=L- cystine di tert butyl carbonate dihydrochloride
Embodiment 1
The skin lightening potentiality of the research present composition of embodiment 1.The result of acquisition is summarized in table 1A.Institute in table
There is the weight % in number expression composition.
The inhibition of table 1A- B16 cell
Statistically significant improvement:
1Compared with culture medium and intermedium control, p < 0.05
2Compared with individual GAP, p < 0.05
3Compared with individual 12- hydroxy stearic acid, p < 0.05
In table 1A, the sample marked by alphabetic character is except the scope of the present invention.The sample of numeral mark is at this
In the range of invention.Sample C in table 1A is positive control, because it uses 4- hexyl resorcin, (known height has
The skin lightening agent of effect).Generally speaking, from the result in table 1A can be seen that with using individual 12- hydroxy stearic acid or
The result that GAP is obtained is compared, and PPAR activation fatty acid (12- hydroxy stearic acid) causes to cooperate with improvement with the combination of GAP amino acid
(synthesis for inhibiting melanin).
Embodiment 2
Embodiment 2 generates the amino acid for having rated and constituting GSH and constructing module for intracellular GSH is enhanced.The result of acquisition
It is summarized in table 2A.The effect of table 2B is into 2D, is also tested for various cystine esters.
Table 2A-glutathione synthesis
Statistically significant reduction:
1Compared with HR+GAP10+ menadione, p < 0.05
Statistically significant improvement:
2Compared with intermedium control+menadione, p < 0.05
Table 2B-glutathione synthesis
Statistically significant reduction:
1Compared with intermedium control, p < 0.05
Statistically significant improvement:
2Compared with intermedium control+menadione, p < 0.05
Table 2C-glutathione synthesis
Statistically significant reduction:
1Compared with intermedium control, p < 0.05
Table 2D-glutathione synthesis
Statistically significant reduction:
1Compared with intermedium control, p < 0.05
Statistically significant improvement:
2Compared with intermedium control+menadione, p < 0.05
Embodiment 3
Embodiment 3 is reduced for the improvement of oxygen species has rated the amino acid for constituting GSH building module.The result of acquisition is converged
Always in table 3A into 3A.The effect of table 3B is also tested for various cystine esters into 3D.
The reduction of table 3A- oxygen species
Statistically-significant difference:
1Compared with intermedium control, p < 0.05
Statistically-significant difference:
2Compared with intermedium control+menadione, p < 0.05
The reduction of table 3B-active oxygen species
Statistically-significant difference:
1Compared with intermedium control, p < 0.05
Statistically-significant difference:
2Compared with intermedium control+menadione, p < 0.05
The reduction of table 3C- oxygen species
Statistically-significant difference:
1Compared with intermedium control, p < 0.05
Statistically-significant difference:
2Compared with intermedium control+menadione, p < 0.05
The reduction of table 3D- oxygen species
Statistically-significant difference:
1Compared with intermedium control, p < 0.05
Statistically-significant difference:
2Compared with intermedium control+menadione, p < 0.05
Embodiment 4
Personal nursing formulation according to the present invention is shown in following table.All numbers in table indicate the weight in composition
Measure %.
Table I-oil-in-water formulation, emulsion and creme
Table II-Water-In-Oil topical cream or creme
Table III-toilet cream
Claims (15)
1. a kind of local skin lightening composition, it includes:
A. skin lightening additive, the poidometer with the composition includes:
I. the cystine of about 0.001% to about 2%;
Ii. about 0.01 to about 10% selected from the glutamic acid Yanyuan in the following group: glutamine, glutamic acid, pyroglutamic acid and they
Mixture;
Iii. the glycine of about 0.01% to about 10%;With
Iv. the PPAR of about 0.01% to about 5% activates fatty acid;With
B. acceptable carrier on cosmetics;
C. wherein the pH of the composition in the range of about 3.5 to about 8.5.
2. composition according to claim 1, wherein PPAR activates fatty acid in the following group: 12- hydroxy stearic acid,
The cis- sub- oil of -12- conjugation of conjugated linoleic acid, ricinoleic acid, petroselic acid, cis- -9- anti-form-1 1- conjugated linoleic acid, anti-form-1 0-
Acid, the trans- octadecanoid acid of 7-, cis--parinaric acid, docosahexaenoic acid, cis- -4,7,10,13,16,19- 22
Carbon acid, ricinelaidic acid, parinaric acid, octatecatrienoic acid, anti-linolenic acid, vaccenic acid, eicosapentaenoic acid,
The mixture of Pinolenic acid and they.
3. composition according to any one of the preceding claims, wherein the glutamate source be pyroglutamic acid or its
Salt.
4. composition according to any one of the preceding claims, wherein the PPAR activated acids are 12- hydroxy stearic acids.
5. composition according to any one of the preceding claims, wherein the PPAR activated acids are conjugated linoleic acid.
6. composition according to any one of the preceding claims, wherein the PPAR activated acids are petroselic acids.
7. composition according to any one of the preceding claims, wherein the composition is in include the cystine in water phase
Water-in-oil emulsion form, wherein 90% water droplet has diameter in 100 nanometers to 20 microns of size range.
8. composition according to any one of the preceding claims, it includes the selenium sources of 0 to most 0.1%.
9. composition according to any one of the preceding claims, wherein the composition is the non-solid skin of leave
Cosmetic composition.
10. composition according to any one of the preceding claims, wherein the composition is toilet cream.
11. composition according to any one of the preceding claims, wherein the composition further includes between 4- alkyl
Benzenediol.
12. composition according to any one of the preceding claims, wherein the composition further includes niacinamide.
13. composition according to any one of the preceding claims, wherein total amino acid and PPAR activate the weight of fatty acid
Ratio is measured in the range of 10:1 to 20:1.
14. improving the method for the appearance of skin comprising Xiang Suoshu skin applies according to any one of preceding claims
Composition.
15. obtaining even skin tone and reducing pigmentation, senile plaque and the method for discoloration comprising Xiang Suoshu skin applies basis
Composition described in any one of preceding claims.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662437073P | 2016-12-21 | 2016-12-21 | |
US62/437,073 | 2016-12-21 | ||
PCT/CN2017/117008 WO2018113636A1 (en) | 2016-12-21 | 2017-12-18 | Topical skin lightening additive and composition with amino acids and ppar activating fatty acids |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110121329A true CN110121329A (en) | 2019-08-13 |
CN110121329B CN110121329B (en) | 2022-04-12 |
Family
ID=62624721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780079471.8A Active CN110121329B (en) | 2016-12-21 | 2017-12-18 | Topical skin lightening additives and compositions with amino acids and PPAR-activated fatty acids |
Country Status (5)
Country | Link |
---|---|
US (1) | US20200009034A1 (en) |
EP (1) | EP3558245B1 (en) |
CN (1) | CN110121329B (en) |
CA (1) | CA3046137A1 (en) |
WO (1) | WO2018113636A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116056684A (en) * | 2020-07-30 | 2023-05-02 | 联合利华知识产权控股有限公司 | Personal care compositions comprising atractylenolide-I or a source of atractylenolide-I |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110325168B (en) | 2016-12-21 | 2022-10-21 | 联合利华知识产权控股有限公司 | Personal care compositions containing cystine |
US11260005B2 (en) | 2016-12-21 | 2022-03-01 | Conopco, Inc. | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids |
CN112165927B (en) * | 2018-05-23 | 2024-01-30 | 联合利华知识产权控股有限公司 | Nanoemulsion and preparation method thereof |
WO2021219376A1 (en) | 2020-04-28 | 2021-11-04 | Unilever Ip Holdings B.V. | Personal care compositions with enhanced solubility actives |
WO2022136357A1 (en) * | 2020-12-24 | 2022-06-30 | Unilever Ip Holdings B.V. | Prolipid composition for personalized benefits and method for using the same |
WO2023126136A1 (en) * | 2021-12-31 | 2023-07-06 | Unilever Ip Holdings B.V. | Personal care composition |
BE1030448B1 (en) * | 2022-10-26 | 2023-11-10 | Alphascience Res | Glutamine acid-tannic complex |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101773458A (en) * | 2009-01-12 | 2010-07-14 | 孙海 | Skin-refreshing jelly whitening and protective creamy foundation |
CN101835449A (en) * | 2007-08-31 | 2010-09-15 | Dsmip资产有限公司 | 4-amidino benzylamines for cosmetic and/or dermatological use |
KR20150017207A (en) * | 2013-08-06 | 2015-02-16 | 주식회사 엘지생활건강 | Compositions comprising Atractyloides japonica rhizome extract and Tranexamic acid for whitening |
CN105658198A (en) * | 2013-10-25 | 2016-06-08 | 荷兰联合利华有限公司 | Skin lightening composition |
CN105919827A (en) * | 2016-06-01 | 2016-09-07 | 北京希诺赛尔健康科技推广有限公司 | Skin care composition with moisturizing and wrinkle-resistant effects |
EP3103434A1 (en) * | 2008-06-18 | 2016-12-14 | Unilever N.V. | Compositions for lightening skin color |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120214871A1 (en) * | 2011-02-17 | 2012-08-23 | Conopco, Inc., D/B/A Unilever | Leave-on nonsolid oil-continuous skin conditioning compositions containing 12-hydroxystearic acid |
WO2018113637A1 (en) * | 2016-12-21 | 2018-06-28 | Unilever Plc | Personal care compositions with glutathione precursor comprising nicotinamide and amino acids |
US11260005B2 (en) * | 2016-12-21 | 2022-03-01 | Conopco, Inc. | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids |
-
2017
- 2017-12-18 CN CN201780079471.8A patent/CN110121329B/en active Active
- 2017-12-18 CA CA3046137A patent/CA3046137A1/en active Pending
- 2017-12-18 EP EP17882292.0A patent/EP3558245B1/en active Active
- 2017-12-18 US US16/470,426 patent/US20200009034A1/en active Pending
- 2017-12-18 WO PCT/CN2017/117008 patent/WO2018113636A1/en active Search and Examination
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101835449A (en) * | 2007-08-31 | 2010-09-15 | Dsmip资产有限公司 | 4-amidino benzylamines for cosmetic and/or dermatological use |
EP3103434A1 (en) * | 2008-06-18 | 2016-12-14 | Unilever N.V. | Compositions for lightening skin color |
CN101773458A (en) * | 2009-01-12 | 2010-07-14 | 孙海 | Skin-refreshing jelly whitening and protective creamy foundation |
KR20150017207A (en) * | 2013-08-06 | 2015-02-16 | 주식회사 엘지생활건강 | Compositions comprising Atractyloides japonica rhizome extract and Tranexamic acid for whitening |
CN105658198A (en) * | 2013-10-25 | 2016-06-08 | 荷兰联合利华有限公司 | Skin lightening composition |
CN105919827A (en) * | 2016-06-01 | 2016-09-07 | 北京希诺赛尔健康科技推广有限公司 | Skin care composition with moisturizing and wrinkle-resistant effects |
Non-Patent Citations (3)
Title |
---|
LABORATOIRES FILORGA: "Meso-Mask Anti-Wrinkle Lightening Mask", 《DATABASE GNPD》 * |
国家食品药品监督管理总局: "《化妆品安全技术规范》", 30 November 2015, 国家食品药品监督管理总局 * |
李玉兰: "《微量元素硒的生物医学功效及检测方法》", 31 May 2008, 黑龙江人民出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116056684A (en) * | 2020-07-30 | 2023-05-02 | 联合利华知识产权控股有限公司 | Personal care compositions comprising atractylenolide-I or a source of atractylenolide-I |
Also Published As
Publication number | Publication date |
---|---|
US20200009034A1 (en) | 2020-01-09 |
CA3046137A1 (en) | 2018-06-28 |
WO2018113636A1 (en) | 2018-06-28 |
EP3558245A1 (en) | 2019-10-30 |
CN110121329B (en) | 2022-04-12 |
EP3558245B1 (en) | 2024-02-07 |
EP3558245A4 (en) | 2020-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110121329A (en) | Local skin blast additive and composition with amino acid and PPAR activation fatty acid | |
CN110121332A (en) | With the personal care composition comprising niacinamide and the glutathione precursor of amino acid | |
CN110121331B (en) | Personal care compositions containing poorly soluble compounds | |
US11759412B2 (en) | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids | |
CN110099672A (en) | Local skin blast additive and composition with amino acid and nicotinamide compounds | |
US9492492B2 (en) | Compositions comprising Lilium martagon extracts and uses thereof | |
US8293293B2 (en) | Compositions comprising Lilium martagon extracts and uses thereof | |
US20120157939A1 (en) | Compositions comprising lilium siberia extracts and uses thereof | |
CN110325168A (en) | Personal care composition containing cystine | |
CN109562043A (en) | Personal care composition comprising fatty acid amide derivant | |
EA039773B1 (en) | Personal care compositions with glutathione precursor comprising nicotinamide and amino acids | |
EP2465489B1 (en) | Compositions comprising lilium martagon extracts and uses thereof | |
EA042158B1 (en) | METHOD FOR PRODUCING COMPOSITION FOR PERSONAL HYGIENE CONTAINING CYSTINE AND COMPOSITION OBTAINED BY THE SPECIFIED METHOD |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210910 Address after: Rotterdam Applicant after: Unilever Intellectual Property Holdings Ltd. Address before: Rotterdam Applicant before: Unilever Nederland B.V. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |